Endometrial carcinoma is a malignant epithelial tumor that forms in the inner lining, or endometrium, of the uterus. Endometrial carcinoma is the most common gynecologic malignancy. Approximately two-thirds of endometrial carcinoma cases are diagnosed with disease confined to the uterus. The complete NCCN Guidelines for Uterine Neoplasms provide recommendations for the diagnosis, evaluation, and treatment of endometrial cancer and uterine sarcoma. This manuscript discusses guiding principles for the diagnosis, staging, and treatment of early-stage endometrial carcinoma as well as evidence for these recommendations.

  • 1.

    SiegelRLMillerKDJemalA. Cancer Statistics, 2017. CA Cancer J Clin2017;67:730.

  • 2.

    D'AngeloEPratJ. Uterine sarcomas: a review. Gynecol Oncol2010;116:131139.

  • 3.

    SiegelRLMillerKDJemalA. Cancer statistics, 2016. CA Cancer J Clin2016;66:730.

  • 4.

    Van den BoschTCoosemansAMorinaM. Screening for uterine tumours. Best Pract Res Clin Obstet Gynaecol2012;26:257266.

  • 5.

    KitchenerHCTrimbleEL. Endometrial cancer state of the science meeting. Int J Gynecol Cancer2009;19:134140.

  • 6.

    DinkelspielHEWrightJDLewinSNHerzogTJ. Contemporary clinical management of endometrial cancer. Obstet Gynecol Int2013;2013:583891.

  • 7.

    ObermairAYouldenDRYoungJP. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer2010;127:26782684.

    • Search Google Scholar
    • Export Citation
  • 8.

    UedaSMKappDSCheungMK. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol2008;198:218 e211e216.

    • Search Google Scholar
    • Export Citation
  • 9.

    ChanJKShermanAEKappDS. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol2011;29:832838.

    • Search Google Scholar
    • Export Citation
  • 10.

    Benedetti PaniciPBasileSSalernoMG. Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma. Am J Obstet Gynecol2014;210:363.e1363.e10.

    • Search Google Scholar
    • Export Citation
  • 11.

    DollKMTsengJDenslowSA. High-grade endometrial cancer: revisiting the impact of tumor size and location on outcomes. Gynecol Oncol2014;132:4449.

    • Search Google Scholar
    • Export Citation
  • 12.

    ResnickKEHampelHFishelRCohnDE. Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. Gynecol Oncol2009;114:128134.

    • Search Google Scholar
    • Export Citation
  • 13.

    KwonJSScottJLGilksCB. Testing women with endometrial cancer to detect Lynch syndrome. J Clin Oncol2011;29:22472252.

  • 14.

    BuchananDDTanYYWalshMD. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. J Clin Oncol2014;32:90100.

    • Search Google Scholar
    • Export Citation
  • 15.

    FergusonSEAronsonMPollettA. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Cancer2014;120:39323939.

    • Search Google Scholar
    • Export Citation
  • 16.

    GoodfellowPJBillingsleyCCLankesHA. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. J Clin Oncol2015;33:43014308.

    • Search Google Scholar
    • Export Citation
  • 17.

    WatkinsJCYangEJMutoMG. Universal screening for mismatch-repair deficiency in endometrial cancers to identify patients with Lynch syndrome and Lynch-like syndrome. Int J Gynecol Pathol2017;36:115127.

    • Search Google Scholar
    • Export Citation
  • 18.

    MillsAMLiouSFordJM. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol2014;38:15011509.

    • Search Google Scholar
    • Export Citation
  • 19.

    SmithRACokkinidesVBrawleyOW. Cancer screening in the United States, 2012: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin2012;62:129142.

    • Search Google Scholar
    • Export Citation
  • 20.

    CrispensMA. Endometrial and ovarian cancer in lynch syndrome. Clin Colon Rectal Surg2012;25:97102.

  • 21.

    ManchandaRSaridoganEAbdelraheimA. Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS). Arch Gynecol Obstet2012;286:15551562.

    • Search Google Scholar
    • Export Citation
  • 22.

    MeyerLABroaddusRRLuKH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control2009;16:1422.

  • 23.

    JarvinenHJRenkonen-SinisaloLAktan-CollanK. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol2009;27:47934797.

    • Search Google Scholar
    • Export Citation
  • 24.

    SchmelerKMLynchHTChenLM. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med2006;354:261269.

    • Search Google Scholar
    • Export Citation
  • 25.

    McCluggageWG. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol2006;59:801812.

  • 26.

    McKenneyJKLongacreTA. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics. Adv Anat Pathol2009;16:122.

    • Search Google Scholar
    • Export Citation
  • 27.

    LeitaoMMJr.KehoeSBarakatRR. Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol2009;113:105108.

    • Search Google Scholar
    • Export Citation
  • 28.

    GimpelsonRJRappoldHO. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. a review of 276 cases. Am J Obstet Gynecol1988;158:489492.

    • Search Google Scholar
    • Export Citation
  • 29.

    LeeJHDubinskyTAndreottiRF. ACR appropriateness criteria(R) pretreatment evaluation and follow-up of endometrial cancer of the uterus. Ultrasound Q2011;27:139145.

    • Search Google Scholar
    • Export Citation
  • 30.

    OrtashiOJainSEmannuelO. Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer. A prospective study of 100 cases at the Dorset Cancer Centre. Eur J Obstet Gynecol Reprod Biol2008;137:232235.

    • Search Google Scholar
    • Export Citation
  • 31.

    CrivellaroCSignorelliMGuerraL. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Gynecol Oncol2013;130:306311.

    • Search Google Scholar
    • Export Citation
  • 32.

    KitajimaKSuzukiKSendaM. Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone?Ann Nucl Med2011;25:511519.

    • Search Google Scholar
    • Export Citation
  • 33.

    AntonsenSLJensenLNLoftA. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. Gynecol Oncol2013;128:300308.

    • Search Google Scholar
    • Export Citation
  • 34.

    BollineniVRYtre-HaugeSBollineni-BalabayO. High diagnostic value of 18F-FDG PET/CT in endometrial cancer: systematic review and meta-analysis of the literature. J Nucl Med2016;57:879885.

    • Search Google Scholar
    • Export Citation
  • 35.

    DukJMAaldersJGFleurenGJde BruijnHW. CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol1986;155:10971102.

  • 36.

    DukJMAaldersJGFleurenGJ. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Obstet Gynecol1989;73:661668.

    • Search Google Scholar
    • Export Citation
  • 37.

    PatsnerBOrrJWJr.MannWJJr.Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinoma. Am J Obstet Gynecol1990;162:427429.

    • Search Google Scholar
    • Export Citation
  • 38.

    RosePGSommersRMRealeFR. Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma. Obstet Gynecol1994;84:1216.

    • Search Google Scholar
    • Export Citation
  • 39.

    PriceFVChambersSKCarcangiuML. CA 125 may not reflect disease status in patients with uterine serous carcinoma. Cancer1998;82:17201725.

    • Search Google Scholar
    • Export Citation
  • 40.

    LeslieKKThielKWGoodheartMJ. Endometrial cancer. Obstet Gynecol Clin North Am2012;39:255268.

  • 41.

    SmithRABrooksDCokkinidesV. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin2013;63:88105.

    • Search Google Scholar
    • Export Citation
  • 42.

    BoronowRCMorrowCPCreasmanWT. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol1984;63:825832.

    • Search Google Scholar
    • Export Citation
  • 43.

    CowlesTAMagrinaJFMastersonBJCapenCV. Comparison of clinical and surgical-staging in patients with endometrial carcinoma. Obstet Gynecol1985;66:413416.

    • Search Google Scholar
    • Export Citation
  • 44.

    CreasmanWTMorrowCPBundyBN. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer1987;60:20352041.

    • Search Google Scholar
    • Export Citation
  • 45.

    BenedetJLBenderHJonesH. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet2000;70:209262.

    • Search Google Scholar
    • Export Citation
  • 46.

    WrightJDBarrena MedelNISehouliJ. Contemporary management of endometrial cancer. Lancet2012;379:13521360.

  • 47.

    PecorelliS. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet2009;105:103104.

  • 48.

    CreasmanW. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet2009;105:109.

  • 49.

    MarianiADowdySCPodratzKC. New surgical staging of endometrial cancer: 20 years later. Int J Gynaecol Obstet2009;105:110111.

  • 50.

    AminMBEdgeSBGreeneFL. AJCC Cancer Staging Manual8th edition. New York: Springer; 2017.

  • 51.

    WethingtonSLBarrena MedelNIWrightJDHerzogTJ. Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: Unraveling a mystery. Gynecol Oncol2009;115:1825.

    • Search Google Scholar
    • Export Citation
  • 52.

    TakeshimaNNishidaHTabataT. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol2001;82:470473.

    • Search Google Scholar
    • Export Citation
  • 53.

    GoffBARiceLW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol1990;38:4648.

  • 54.

    DanielAGPetersWA3rd. Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet Gynecol1988;71:612614.

    • Search Google Scholar
    • Export Citation
  • 55.

    SolimanPTFrumovitzMSpannuthW. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol2010;119:291294.

    • Search Google Scholar
    • Export Citation
  • 56.

    KumarSMarianiABakkum-GamezJN. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer. Gynecol Oncol2013;130:441445.

    • Search Google Scholar
    • Export Citation
  • 57.

    KilgoreLCPartridgeEEAlvarezRD. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol1995;56:2933.

    • Search Google Scholar
    • Export Citation
  • 58.

    HavrileskyLJCragunJMCalingaertB. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol2005;99:689695.

    • Search Google Scholar
    • Export Citation
  • 59.

    TodoYKatoHKaneuchiM. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet2010;375:11651172.

    • Search Google Scholar
    • Export Citation
  • 60.

    KitchenerHSwartAMQianQ. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet2009;373:125136.

    • Search Google Scholar
    • Export Citation
  • 61.

    Benedetti PaniciPBasileSManeschiF. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst2008;100:17071716.

    • Search Google Scholar
    • Export Citation
  • 62.

    ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol2005;106:413425.

    • Search Google Scholar
    • Export Citation
  • 63.

    SeamonLGFowlerJMCohnDE. Lymphadenectomy for endometrial cancer: the controversy. Gynecol Oncol2010;117:68.

  • 64.

    CreasmanWTMutchDEHerzogTJ. ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid?Gynecol Oncol2010;116:293294.

  • 65.

    UccellaSPodratzKCAlettiGDMarianiA. Lymphadenectomy in endometrial cancer. Lancet2009;373:1170; author reply 1170–1171.

  • 66.

    UccellaSPodratzKCAlettiGDMarianiA. Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst2009;101:897898; author reply 898–899.

    • Search Google Scholar
    • Export Citation
  • 67.

    MilamMRJavaJWalkerJL. Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol2012;119:286292.

  • 68.

    NeubauerNLLurainJR. The role of lymphadenectomy in surgical staging of endometrial cancer. Int J Surg Oncol2011;2011:814649.

  • 69.

    MarianiADowdySCClibyWA. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol2008;109:1118.

    • Search Google Scholar
    • Export Citation
  • 70.

    HirahatakeKHareyamaHSakuragiN. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol1997;65:8287.

    • Search Google Scholar
    • Export Citation
  • 71.

    FrederickPJStraughnJMJr.The role of comprehensive surgical staging in patients with endometrial cancer. Cancer Control2009;16:2329.

  • 72.

    BarlinJNKhoury-ColladoFKimCH. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol2012;125:531535.

    • Search Google Scholar
    • Export Citation
  • 73.

    BallesterMKoskasMCoutantC. Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?BMC Cancer2010;10:465.

    • Search Google Scholar
    • Export Citation
  • 74.

    HowJLauSPressJ. Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: a prospective study. Gynecol Oncol2012;127:332337.

    • Search Google Scholar
    • Export Citation
  • 75.

    Khoury-ColladoFMurrayMPHensleyML. Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. Gynecol Oncol2011;122:251254.

    • Search Google Scholar
    • Export Citation
  • 76.

    HollowayRWAbu-RustumNRBackesFJ. Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol2017;146:405415.

    • Search Google Scholar
    • Export Citation
  • 77.

    VidalFLeguevaquePMottonS. Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting. Int J Gynecol Cancer2013;23:12371243.

    • Search Google Scholar
    • Export Citation
  • 78.

    KimCHKhoury-ColladoFBarberEL. Sentinel lymph node mapping with pathologic ultrastaging: A valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion. Gynecol Oncol2013.

    • Search Google Scholar
    • Export Citation
  • 79.

    Group SGOCPECWBurkeWMOrrJ. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol2014;134:385392.

  • 80.

    SolimanPTWestinSNDiounS. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol2017;146:234239.

    • Search Google Scholar
    • Export Citation
  • 81.

    Abu-RustumNRKhoury-ColladoFPandit-TaskarN. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?Gynecol Oncol2009;113:163169.

    • Search Google Scholar
    • Export Citation
  • 82.

    BallesterMDubernardGLecuruF. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol2011;12:469476.

    • Search Google Scholar
    • Export Citation
  • 83.

    PressJZGotliebWH. Controversies in the treatment of early stage endometrial carcinoma. Obstet Gynecol Int2012;2012:578490.

  • 84.

    TouhamiOTrinhXBGregoireJ. Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer. Gynecol Oncol2015;138:4145.

    • Search Google Scholar
    • Export Citation
  • 85.

    RossiECKowalskiLDScaliciJ. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol2017;18:384392.

    • Search Google Scholar
    • Export Citation
  • 86.

    PaleyPJVeljovichDSPressJZ. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging. Am J Obstet Gynecol2016;215:117 e111117.

    • Search Google Scholar
    • Export Citation
  • 87.

    SinnoAKFaderANRocheKL. A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer. Gynecol Oncol2014;134:281286.

    • Search Google Scholar
    • Export Citation
  • 88.

    RuscitoIGasparriMLBraicuEI. Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes—a meta-analysis. Ann Surg Oncol2016;23:37493756.

    • Search Google Scholar
    • Export Citation
  • 89.

    Bodurtha SmithAJFaderANTannerEJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol2016.

    • Search Google Scholar
    • Export Citation
  • 90.

    CormierBRozenholcATGotliebW. Sentinel lymph node procedure in endometrial cancer: a systematic review and proposal for standardization of future research. Gynecol Oncol2015;138:478485.

    • Search Google Scholar
    • Export Citation
  • 91.

    NaouraICanlorbeGBendifallahS. Relevance of sentinel lymph node procedure for patients with high-risk endometrial cancer. Gynecol Oncol2015;136:6064.

    • Search Google Scholar
    • Export Citation
  • 92.

    SchiavoneMBZivanovicOZhouQ. Survival of patients with uterine carcinosarcoma undergoing sentinel lymph node mapping. Ann Surg Oncol2016;23:196202.

    • Search Google Scholar
    • Export Citation
  • 93.

    HollowayRWGuptaSStavitzskiNM. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. Gynecol Oncol2016;141:206210.

    • Search Google Scholar
    • Export Citation
  • 94.

    DaraiEDubernardGBatsAS. Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study. Gynecol Oncol2015;136:5459.

    • Search Google Scholar
    • Export Citation
  • 95.

    KimCHSoslowRAParkKJ. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer2013;23:964970.

    • Search Google Scholar
    • Export Citation
  • 96.

    RaimondEBallesterMHudryD. Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: results of a retrospective multicenter study. Gynecol Oncol2014;133:506511.

    • Search Google Scholar
    • Export Citation
  • 97.

    FrimerMKhoury-ColladoFMurrayMP. Micrometastasis of endometrial cancer to sentinel lymph nodes: is it an artifact of uterine manipulation?Gynecol Oncol2010;119:496499.

    • Search Google Scholar
    • Export Citation
  • 98.

    TouboulCBentivegnaEUzanC. Sentinel lymph node in endometrial cancer: a review. Curr Oncol Rep2013;15:559565.

  • 99.

    AmezcuaCAMacDonaldHRLumCA. Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes. Int J Gynecol Cancer2006;16:13361341.

    • Search Google Scholar
    • Export Citation
  • 100.

    TodoYKatoHOkamotoK. Isolated tumor cells and micrometastases in regional lymph nodes in FIGO stage I to II endometrial cancer. J Gynecol Oncol2016;27:e1.

    • Search Google Scholar
    • Export Citation
  • 101.

    SmerageJBBarlowWEHortobagyiGN. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. J Clin Oncol2014;32:34833489.

    • Search Google Scholar
    • Export Citation
  • 102.

    St ClairCMErikssonAGDucieJA. Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma. Ann Surg Oncol2016;23:16531659.

    • Search Google Scholar
    • Export Citation
  • 103.

    PlanteMStanleighJRenaudMC. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: does adjuvant treatment matter?Gynecol Oncol2017;146:240246.

    • Search Google Scholar
    • Export Citation
  • 104.

    ScaliciJLaughlinBBFinanMA. The trend towards minimally invasive surgery (MIS) for endometrial cancer: an ACS-NSQIP evaluation of surgical outcomes. Gynecol Oncol2015;136:512515.

    • Search Google Scholar
    • Export Citation
  • 105.

    JandaMGebskiVDaviesLC. Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: a randomized clinical trial. JAMA2017;317:12241233.

    • Search Google Scholar
    • Export Citation
  • 106.

    FaderANWeiseRMSinnoAK. Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity. Obstet Gynecol2016;127:91100.

    • Search Google Scholar
    • Export Citation
  • 107.

    GalaalKBryantAFisherAD. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev2012:CD006655.

    • Search Google Scholar
    • Export Citation
  • 108.

    KornblithABHuangHQWalkerJL. Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol2009;27:53375342.

    • Search Google Scholar
    • Export Citation
  • 109.

    WalkerJLPiedmonteMRSpirtosNM. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol2009;27:53315336.

    • Search Google Scholar
    • Export Citation
  • 110.

    MannschreckDMatsunoRKMoriartyJP. Disparities in surgical care among women with endometrial cancer. Obstet Gynecol2016;128:526534.

  • 111.

    WalkerJLPiedmonteMRSpirtosNM. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol2012;30:695700.

    • Search Google Scholar
    • Export Citation
  • 112.

    KingLPMillerDS. Recent progress: gynecologic oncology group trials in uterine corpus tumors. Rev Recent Clin Trials2009;4:7074.

  • 113.

    VergoteIAmantFNevenP. Is it safe to treat endometrial carcinoma endoscopically?J Clin Oncol2009;27:53055307.

  • 114.

    MouritsMJBijenCBArtsHJ. Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial. Lancet Oncol2010;11:763771.

    • Search Google Scholar
    • Export Citation
  • 115.

    HeHZengDOuH. Laparoscopic treatment of endometrial cancer: systematic review. J Minim Invasive Gynecol2013;20:413423.

  • 116.

    WangHLRenYFYangJ. Total laparoscopic hysterectomy versus total abdominal hysterectomy for endometrial cancer: a meta-analysis. Asian Pac J Cancer Prev2013;14:25152519.

    • Search Google Scholar
    • Export Citation
  • 117.

    MoriKMNeubauerNL. Minimally invasive surgery in gynecologic oncology. ISRN Obstet Gynecol2013;2013:312982.

  • 118.

    KrillLSBristowRE. Robotic surgery: gynecologic oncology. Cancer J2013;19:167176.

  • 119.

    ElSahwiKSHooperCDe LeonMC. Comparison between 155 cases of robotic vs. 150 cases of open surgical staging for endometrial cancer. Gynecol Oncol2012;124:260264.

    • Search Google Scholar
    • Export Citation
  • 120.

    ChanJKGardnerABTaylorK. Robotic versus laparoscopic versus open surgery in morbidly obese endometrial cancer patients—a comparative analysis of total charges and complication rates. Gynecol Oncol2015;139:300305.

    • Search Google Scholar
    • Export Citation
  • 121.

    CoronadoPJHerraizMAMagrinaJF. Comparison of perioperative outcomes and cost of robotic-assisted laparoscopy, laparoscopy and laparotomy for endometrial cancer. Eur J Obstet Gynecol Reprod Biol2012;165:289294.

    • Search Google Scholar
    • Export Citation
  • 122.

    SeamonLGCohnDEHenrettaMS. Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy?Gynecol Oncol2009;113:3641.

    • Search Google Scholar
    • Export Citation
  • 123.

    BellMCTorgersonJSeshadri-KreadenU. Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques. Gynecol Oncol2008;111:407411.

    • Search Google Scholar
    • Export Citation
  • 124.

    Cardenas-GoicoecheaJAdamsSBhatSBRandallTC. Surgical outcomes of robotic-assisted surgical staging for endometrial cancer are equivalent to traditional laparoscopic staging at a minimally invasive surgical center. Gynecol Oncol2010;117:224228.

    • Search Google Scholar
    • Export Citation
  • 125.

    BrudieLABackesFJAhmadS. Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery. Gynecol Oncol2013;128:309315.

    • Search Google Scholar
    • Export Citation
  • 126.

    BackesFJBrudieLAFarrellMR. Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. Gynecol Oncol2012;125:546551.

    • Search Google Scholar
    • Export Citation
  • 127.

    FlemingNDRamirezPT. Robotic surgery in gynecologic oncology. Curr Opin Oncol2012;24:547553.

  • 128.

    SiestoGOrnaghiSIedaNVitobelloD. Robotic surgical staging for endometrial and cervical cancers in medically ill patients. Gynecol Oncol2013;129:593597.

    • Search Google Scholar
    • Export Citation
  • 129.

    van DamPHauspyJVerkinderenL. Are costs of robot-assisted surgery warranted for gynecological procedures?Obstet Gynecol Int2011;2011:973830.

    • Search Google Scholar
    • Export Citation
  • 130.

    WeinbergLRaoSEscobarPF. Robotic surgery in gynecology: an updated systematic review. Obstet Gynecol Int2011;2011:852061.

  • 131.

    RamirezPTAdamsSBoggessJF. Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. Gynecol Oncol2012;124:180184.

    • Search Google Scholar
    • Export Citation
  • 132.

    AAGL. Guidelines for privileging for robotic-assisted gynecologic laparoscopy. J Minim Invasive Gynecol2014;21:157167.

  • 133.

    American Congress of Obstetricians and Gynecologists. Statement on Robotic Surgery by ACOG President James T. Breeden. 2013. Available at: http://www.acog.org/About-ACOG/News-Room/News-Releases/2013/Statement-on-Robotic-Surgery. Accessed March 182013.

    • Search Google Scholar
    • Export Citation
  • 134.

    SinnoAKFaderAN. Robotic-assisted surgery in gynecologic oncology. Fertil Steril2014;102:922932.

  • 135.

    GalaRBMarguliesRSteinbergA. Systematic review of robotic surgery in gynecology: robotic techniques compared with laparoscopy and laparotomy. J Minim Invasive Gynecol2014;21:353361.

    • Search Google Scholar
    • Export Citation
  • 136.

    SGO Position Statement: Morcellation. Society of Gynecologic Oncology; 2013. Available at: https://www.sgo.org/newsroom/position-statements-2/morcellation/. Accessed September 30 2014.

    • Search Google Scholar
    • Export Citation
  • 137.

    Power Morcellation and Occult Malignancy in Gynecologic Surgery. The American College of Obstetrics and Gynecologists; 2014. Available at: http://www.acog.org/Resources-And-Publications/Task-Force-and-Work-Group-Reports/Power-Morcellation-and-Occult-Malignancy-in-Gynecologic-Surgery. Accessed September 30 2014.

    • Search Google Scholar
    • Export Citation
  • 138.

    U.S. Department of Health and Human Services. FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroidsFood and Drug Administration; 2014. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm393689.htm. Accessed September 30 2014.

    • Search Google Scholar
    • Export Citation
  • 139.

    BoganiGClibyWAAlettiGD. Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis. Gynecol Oncol2015;137:167172.

    • Search Google Scholar
    • Export Citation
  • 140.

    WrightJDBuckAMShahM. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol2009;27:12141219.

  • 141.

    KoskasMBendifallahSLutonD. Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery. Fertil Steril2012;98:12291235.

    • Search Google Scholar
    • Export Citation
  • 142.

    LeeTSLeeJYKimJW. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: A Korean Gynecologic Oncology Group study. Gynecol Oncol2013;131:289293.

    • Search Google Scholar
    • Export Citation
  • 143.

    ManfrediRMirkPMarescaG. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology2004;231:372378.

    • Search Google Scholar
    • Export Citation
  • 144.

    AkinOMironovSPandit-TaskarNHannLE. Imaging of uterine cancer. Radiol Clin North Am2007;45:167182.

  • 145.

    GundersonCCFaderANCarsonKABristowRE. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol2012;125:477482.

    • Search Google Scholar
    • Export Citation
  • 146.

    BakerJObermairAGebskiVJandaM. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature. Gynecol Oncol2012;125:263270.

    • Search Google Scholar
    • Export Citation
  • 147.

    GraciaCRJerussJS. Lives in the balance: women with cancer and the right to fertility care. J Clin Oncol2013;31:668669.

  • 148.

    UshijimaKYahataHYoshikawaH. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol2007;25:27982803.

    • Search Google Scholar
    • Export Citation
  • 149.

    HubbsJLSaigRMAbaidLN. Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma. Obstet Gynecol2013;121:11721180.

    • Search Google Scholar
    • Export Citation
  • 150.

    TrimbleCLMethodMLeitaoM. Management of endometrial precancers. Obstet Gynecol2012;120:11601175.

  • 151.

    MehassebMKLatimerJA. Controversies in the management of endometrial carcinoma: an update. Obstet Gynecol Int2012;2012:676032.

  • 152.

    HahnHSYoonSGHongJS. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer2009;19:10681073.

    • Search Google Scholar
    • Export Citation
  • 153.

    ParkJYKimDYKimJH. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J Cancer2013;49:868874.

    • Search Google Scholar
    • Export Citation
  • 154.

    ParkJYSeongSJKimTJ. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. Obstet Gynecol2013;121:136142.

    • Search Google Scholar
    • Export Citation
  • 155.

    BoenteMPYordanELJr.McIntoshDG. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol1993;51:316322.

    • Search Google Scholar
    • Export Citation
  • 156.

    SartoriEGadducciALandoniF. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer2001;11:430437.

    • Search Google Scholar
    • Export Citation
  • 157.

    GadducciACosioSGenazzaniAR. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: hormonal therapy, chemotherapy and molecularly targeted therapies. Crit Rev Oncol Hematol2006;58:242256.

    • Search Google Scholar
    • Export Citation
  • 158.

    MountziosGPectasidesDBournakisE. Developments in the systemic treatment of endometrial cancer. Crit Rev Oncol Hematol2011;79:278292.

    • Search Google Scholar
    • Export Citation
  • 159.

    FioricaJVBrunettoVLHanjaniP. Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol2004;92:1014.

    • Search Google Scholar
    • Export Citation
  • 160.

    AltmanADThompsonJNelsonG. Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study. J Obstet Gynaecol Can2012;34:664672.

    • Search Google Scholar
    • Export Citation
  • 161.

    BarkerLCBrandIRCrawfordSM. Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma. Curr Med Res Opin2009;25:11051109.

    • Search Google Scholar
    • Export Citation
  • 162.

    RosePGBrunettoVLVanLeL. A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol2000;78:212216.

    • Search Google Scholar
    • Export Citation
  • 163.

    DecruzeSBGreenJA. Hormone therapy in advanced and recurrent endometrial cancer: a systematic review. Int J Gynecol Cancer2007;17:964978.

    • Search Google Scholar
    • Export Citation
  • 164.

    FishmanDARobertsKBChambersJT. Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometrium. Gynecol Oncol1996;61:189196.

    • Search Google Scholar
    • Export Citation
  • 165.

    CoonDBeriwalSHeronDE. High-dose-rate Rotte “Y” applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results. Int J Radiat Oncol Biol Phys2008;71:779783.

    • Search Google Scholar
    • Export Citation
  • 166.

    NiaziTMSouhamiLPortelanceL. Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma. Int J Radiat Oncol Biol Phys2005;63:11081113.

    • Search Google Scholar
    • Export Citation
  • 167.

    van der Steen-BanasikEChristiaensMShashE. Systemic review: radiation therapy alone in medical non-operable endometrial carcinoma. Eur J Cancer2016;65:172181.

    • Search Google Scholar
    • Export Citation
  • 168.

    CreutzbergCLvan StiphoutRGNoutRA. Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: a pooled analysis of PORTEC-1 and PORTEC-2 trials. Int J Radiat Oncol Biol Phys2015;91:530539.

    • Search Google Scholar
    • Export Citation
  • 169.

    Group SGOCPECWBurkeWMOrrJ. Endometrial cancer: a review and current management strategies: part II. Gynecol Oncol2014;134:393402.

  • 170.

    CreutzbergCLNoutRA. The role of radiotherapy in endometrial cancer: current evidence and trends. Curr Oncol Rep2011;13:472478.

  • 171.

    KloppASmithBDAlektiarK. The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol2014;4:137144.

    • Search Google Scholar
    • Export Citation
  • 172.

    MeyerLABohlkeKPowellMA. Postoperative radiation therapy for endometrial cancer: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology evidence-based guideline. J Clin Oncol2015;33:29082913.

    • Search Google Scholar
    • Export Citation
  • 173.

    MorrowCPBundyBNKurmanRJ. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol1991;40:5565.

    • Search Google Scholar
    • Export Citation
  • 174.

    NeubauerNLHavrileskyLJCalingaertB. The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma. Gynecol Oncol2009;112:511516.

    • Search Google Scholar
    • Export Citation
  • 175.

    GretzHFrEconomosKHusainA. The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol1996;61:409415.

    • Search Google Scholar
    • Export Citation
  • 176.

    Ben-ShacharIPavelkaJCohnDE. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol2005;105:487493.

    • Search Google Scholar
    • Export Citation
  • 177.

    ElshaikhMAAl-WahabZMahdiH. Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study. Gynecol Oncol2015;136:235239.

    • Search Google Scholar
    • Export Citation
  • 178.

    CreutzbergCLvan PuttenWLKoperPC. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet2000;355:14041411.

    • Search Google Scholar
    • Export Citation
  • 179.

    AaldersJAbelerVKolstadPOnsrudM. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol1980;56:419427.

    • Search Google Scholar
    • Export Citation
  • 180.

    BlakePSwartAMOrtonJ. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet2009;373:137146.

    • Search Google Scholar
    • Export Citation
  • 181.

    KeysHMRobertsJABrunettoVL. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol2004;92:744751.

    • Search Google Scholar
    • Export Citation
  • 182.

    CreutzbergCLvan PuttenWLJWárlám-RodenhuisCC. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol2004;22:12341241.

    • Search Google Scholar
    • Export Citation
  • 183.

    ScholtenANvan PuttenWLJBeermanH. Postoperative radiotherapy for stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys2005;63:834838.

    • Search Google Scholar
    • Export Citation
  • 184.

    HockelMDornhoferN. Treatment of early endometrial carcinoma: is less more?Lancet2009;373:9799.

  • 185.

    CreutzbergCLNoutRALybeertML. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma. Int J Radiat Oncol Biol Phys2011;81:e631638.

    • Search Google Scholar
    • Export Citation
  • 186.

    AlektiarKMVenkatramanEChiDSBarakatRR. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys2005;62:111117.

    • Search Google Scholar
    • Export Citation
  • 187.

    NoutRASmitVTPutterH. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet2010;375:816823.

    • Search Google Scholar
    • Export Citation
  • 188.

    SmallWJr.BeriwalSDemanesDJ. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy2012;11:5867.

    • Search Google Scholar
    • Export Citation
  • 189.

    OnsrudMCvancarovaMHellebustTP. Long-term outcomes after pelvic radiation for early-stage endometrial cancer. J Clin Oncol2013;31:39513956.

    • Search Google Scholar
    • Export Citation
  • 190.

    NoutRAPutterHJurgenliemk-SchulzIM. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. Eur J Cancer2012;48:16381648.

    • Search Google Scholar
    • Export Citation
  • 191.

    RoperBAstnerSTHeydemann-ObradovicA. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients. Gynecol Oncol2007;107:541548.

    • Search Google Scholar
    • Export Citation
  • 192.

    NoutRAPutterHJurgenliemk-SchulzIM. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol2009;27:35473556.

    • Search Google Scholar
    • Export Citation
  • 193.

    McCloskeySATchaboNEMalhotraHK. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecol Oncol2010;116:404407.

    • Search Google Scholar
    • Export Citation
  • 194.

    DunnEFGeyeHPlattaCS. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer. Gynecol Oncol2014;133:494498.

    • Search Google Scholar
    • Export Citation
  • 195.

    RandallMEFiliaciVMcMeekinDS. A phase 3 trial of pelvic radiation therapy versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy in patients with high-risk, early-stage endometrial cancer: a Gynecology Oncology Group study [abstract]. Int J Radiat Oncol Biol Phys2017.

    • Search Google Scholar
    • Export Citation
  • 196.

    ChinoJPJonesEBerchuckA. The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer. Int J Radiat Oncol Biol Phys2012;82:18721879.

    • Search Google Scholar
    • Export Citation
  • 197.

    LeeCMSzaboAShrieveDC. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA2006;295:389397.

    • Search Google Scholar
    • Export Citation
  • 198.

    JohnsonNCornesP. Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis. BJOG2007;114:13131320.

    • Search Google Scholar
    • Export Citation
  • 199.

    KongAJohnsonNCornesP. Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev2007.

  • 200.

    KongAJohnsonNKitchenerHCLawrieTA. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst2012;104:16251634.

    • Search Google Scholar
    • Export Citation
  • 201.

    EifelPJ. The role of adjuvant radiation therapy for stage I endometrial cancer: does meta-analysis reveal the answer?J Natl Cancer Inst2012;104:16151616.

    • Search Google Scholar
    • Export Citation
  • 202.

    ParkHJNamEJKimS. The benefit of adjuvant chemotherapy combined with postoperative radiotherapy for endometrial cancer: a meta-analysis. Eur J Obstet Gynecol Reprod Biol2013;170:3944.

    • Search Google Scholar
    • Export Citation
  • 203.

    HogbergTSignorelliMde OliveiraCF. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer—results from two randomised studies. Eur J Cancer2010;46:24222431.

    • Search Google Scholar
    • Export Citation
  • 204.

    JohnsonNBryantAMilesT. Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database Syst Rev2011:CD003175.

  • 205.

    MusteaAKoensgenDBelauA. Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology). Cancer Chemother Pharmacol2013;72:975983.

    • Search Google Scholar
    • Export Citation
  • 206.

    JutziLHoskinsPLimP. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma. Gynecol Oncol2013;131:581585.

    • Search Google Scholar
    • Export Citation
  • 207.

    de BoerSMPowellMEMileshkinL. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial. Lancet Oncol2016;17:11141126.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 1 1 0
Full Text Views 3651 3651 416
PDF Downloads 1280 1280 172
EPUB Downloads 0 0 0